NCT02074358View on ClinicalTrials.gov

A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Anticoagulation
Interventions
DRUG

Apixaban

DRUG

Cofact (4-Factor PCC)

DRUG

Beriplex P/N (4-Factor PCC)

DRUG

Placebo (Saline solution)

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY